Form 4: Nuvalent CEO Exercises Options, Sells Shares
Insider Transaction Report
Nuvalent Inc.'s President and CEO, James Richard Porter, exercised stock options and subsequently sold a portion of his Class A Common Stock under a pre-arranged 10b5-1 trading plan.
Summary
- James Richard Porter, President and CEO of Nuvalent, Inc. (NUVL), reported transactions involving the company's Class A Common Stock.
- On October 16, 2025, Porter acquired 27,000 shares of Class A Common Stock through the exercise of stock options at a price of $18.93 per share.
- Following the option exercise, Porter disposed of a total of 27,000 shares of Class A Common Stock through multiple sales transactions on the same date.
- The sales were executed at weighted average prices ranging from $90.01 to $92.63 per share.
- All reported transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Porter on April 2, 2024.
- After these transactions, Porter's direct beneficial ownership of Class A Common Stock stands at 249,062 shares.
- The stock options exercised were part of a grant where 25% vested on January 4, 2023, with the remainder vesting over three years in equal monthly installments, subject to continued service.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the fact that these transactions were pre-planned under a Rule 10b5-1 plan mitigates concerns about opportunistic selling. It primarily reflects an executive realizing value from vested options, which is a routine part of executive compensation.
Positives
- The executive is realizing value from previously granted stock options, indicating a successful vesting and appreciation of the company's stock price.
- The transactions were executed under a Rule 10b5-1 trading plan, which demonstrates pre-planning and can mitigate concerns about opportunistic insider selling.
Negatives
- The sale of a significant number of shares by a key executive, even if planned, could be perceived negatively by some investors as a reduction in insider ownership.
Future Outlook
NA
Industry Context
Insider transactions, particularly those involving option exercises and subsequent sales, are common occurrences for executives in publicly traded companies across all industries. These transactions often reflect personal financial planning, diversification strategies, or the realization of compensation benefits, rather than a direct commentary on the company's immediate prospects. The use of a Rule 10b5-1 plan is a standard practice to manage such transactions in compliance with insider trading regulations.
Stakeholder Impact
- Shareholders: The exercise of options and subsequent sale by a key executive can impact shareholder perception, though the pre-planned nature reduces negative signaling. It also represents the executive realizing value from their equity stake.
- Employees: The vesting schedule of the options is tied to continued service, which aligns executive incentives with long-term company performance.
Next Steps
- The remaining unvested shares underlying the stock option will continue to vest over the three years following January 4, 2023, in equal monthly installments, subject to continued service to Nuvalent, Inc.
Key Dates
| Date | Description |
|---|---|
| 01/04/2023 | Date when 25% of the underlying stock options vested. |
| 04/02/2024 | Date the Rule 10b5-1 trading plan was adopted by James Richard Porter. |
| 10/16/2025 | Date of stock option exercise and subsequent sale transactions. |
| 01/04/2032 | Expiration date of the stock options. |
| 10/17/2025 | Date the Form 4 was signed. |
Keywords
Nuvalent, NUVL, Insider Trading, Form 4, Stock Options, Executive Compensation, 10b5-1 Plan, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.